These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6792441)

  • 1. Tyrosine availability and dopamine synthesis in the striatum: studies with gamma-butyrolactone.
    Sved A; Fernstrom J
    Life Sci; 1981 Aug; 29(7):743-8. PubMed ID: 6792441
    [No Abstract]   [Full Text] [Related]  

  • 2. d-Amphetamine and gamma-butyrolactone alteration of dopamine synthesis in the terminals of nigrostriatal and mesolimbic neurons. Possible role of various autoreceptor sensitivities.
    Demarest KT; Lawson-Wendling KL; Moore KE
    Biochem Pharmacol; 1983 Feb; 32(4):691-7. PubMed ID: 6403019
    [No Abstract]   [Full Text] [Related]  

  • 3. Delayed inhibition of dopamine synthesis by gamma-butyrolactone and baclofen: dopamine autoreceptor supersensitivity?
    Argiolas A; Fadda F; Melis MR; Marcou M; Porceddu ML; Gessa GL
    Eur J Pharmacol; 1982 Nov; 85(1):23-7. PubMed ID: 6818043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of effect of gamma-butyrolactone on amphetamine-induced decrease in striatal synaptosomal dopamine synthesis.
    Kuczenski R
    J Neurochem; 1978 Jul; 31(1):347-9. PubMed ID: 671029
    [No Abstract]   [Full Text] [Related]  

  • 5. Acceleration of the biosynthesis of rat striatal dopamine by incubation and by administration of gamma-butyrolactone.
    Dyck LE; Kazakoff CW
    J Neurosci Res; 1982; 8(1):57-65. PubMed ID: 7175978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered activation of tyrosine hydroxylation by gamma-butyrolactone following chronic ethanol treatment.
    Liljequist S
    Drug Alcohol Depend; 1979; 4(3-4):261-3. PubMed ID: 43241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of pertussis toxin on autoreceptor-mediated inhibition of dopamine synthesis in the rat striatum.
    Bean AJ; Shepard PD; Bunney BS; Nestler EJ; Roth RH
    Mol Pharmacol; 1988 Dec; 34(6):715-8. PubMed ID: 2974120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased striatal dopamine synthesis is associated with decreased tissue levels of tyrosine.
    Bongiovanni R; Young D; Newbould E; Jaskiw GE
    Brain Res; 2006 Oct; 1115(1):26-36. PubMed ID: 16934236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ethanol on the hydroxylation of tyrosine and tryptophan in rat brain in vivo.
    Carlsson A; Lindqvist M
    J Pharm Pharmacol; 1973 Jun; 25(6):437-40. PubMed ID: 4146580
    [No Abstract]   [Full Text] [Related]  

  • 10. Certain dopamine agonists increase dopamine synthesis in the striatum of rat brain.
    Westerink BH; Feenstra MG; Wirix E; Horn AS
    Eur J Pharmacol; 1984 Jun; 101(3-4):235-41. PubMed ID: 6432559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase of dopamine synthesis in synaptosomes from rats treated with neuroleptics or reserpine.
    Tissari AH
    Med Biol; 1982 Feb; 60(1):38-41. PubMed ID: 6121960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of the gamma-butyrolactone-induced increase in DOPA accumulation by chronic ethanol administration.
    Liljequist S; Engel J
    J Neural Transm; 1979; 46(3):195-204. PubMed ID: 528994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and dopamine autoreceptor activity of a 5-(methylmercapto)methyl-substituted derivative of (+/-)-3-PPP (3-(3-hydroxyphenyl)-1-n-propylpiperidine).
    Kelly TR; Howard HR; Koe BK; Sarges R
    J Med Chem; 1985 Sep; 28(9):1368-71. PubMed ID: 3928893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic neurons: reversal of effects elicited by gamma-butyrolactone by stimulation of the nigro-neostriatal pathway.
    Murrin LC; Roth RH
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct; 295(1):15-20. PubMed ID: 12482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feedback control of dopamine synthesis in dopaminergic terminals of the rat striatum.
    Javoy F; Agid Y; Bouvet D; Glowinski J
    J Pharmacol Exp Ther; 1972 Sep; 182(3):454-63. PubMed ID: 4403433
    [No Abstract]   [Full Text] [Related]  

  • 16. Extracellular striatal concentrations of endogenous 3,4-dihydroxyphenylalanine in the absence of a decarboxylase inhibitor: a dynamic index of dopamine synthesis in vivo.
    Carboni E; Tanda G; Di Chiara G
    J Neurochem; 1992 Dec; 59(6):2230-6. PubMed ID: 1431903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum.
    Nissbrandt H; Sundström E; Jonsson G; Hjorth S; Carlsson A
    J Neurochem; 1989 Apr; 52(4):1170-82. PubMed ID: 2564423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An investigation of the relationship between the dopaminergic and electroencephalographic effects of gamma-butyrolactone.
    Snead OC
    Neuropharmacology; 1982 Jun; 21(6):539-43. PubMed ID: 7110537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K+-dependent stimulation of tyrosine hydroxylation in striatal slices: role of Ca2+/calmodulin and Ca2+/phospholipid-dependent mechanisms.
    Knorr AM; Wolf ME; Roth RH
    Biochem Pharmacol; 1986 Jun; 35(12):1929-32. PubMed ID: 2872896
    [No Abstract]   [Full Text] [Related]  

  • 20. (+)- and (-)-3-PPP exhibit different intrinsic activity at striatal dopamine autoreceptors controlling dopamine synthesis.
    Clark D; Hjorth S; Carlsson A
    Eur J Pharmacol; 1984 Oct; 106(1):185-9. PubMed ID: 6099268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.